Brief: Novan Inc - B-Simple4 Pivotal Phase 3 Study In Molluscum Contagiosum Reaches 90% Enrollment With Topline Data Targeted For Q2 2021
19/01/2021 14:42
Jan 19 (Reuters) - Novan Inc NOVN.O :
* NOVAN INC - B-SIMPLE4 PIVOTAL PHASE 3 STUDY IN MOLLUSCUM
CONTAGIOSUM REACHES 90% ENROLLMENT WITH TOPLINE DATA TARGETED
FOR Q2 2021
Source text for Eikon: ID:nGNX2W1FHl
Further company coverage: NOVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NVN Liquidation
See all newsBrief: Nvn Liquidation Says On April 30, Debtors Filed Notice Of Effective Date With Bankruptcy Court
Brief: Novan Received Notice From Nasdaq Notifying Co's Securities Will Be Delisted From Nasdaq
Brief: Novan Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
U.S. STOCKS ON THE MOVE-Lands' End, Energy sector
U.S. STOCKS ON THE MOVE-Biogen, NetApp, LyondellBasell